Synthesis and evaluation of 177Lu-labeled anti-EGFR Fab antibody for lung cancer

被引:0
|
作者
Li, Yuan-Yuan [1 ,2 ]
Yu, Jia-Yan [1 ,2 ]
Wang, Tao [1 ,2 ]
Wang, Jing [2 ,3 ]
Zhao, Peng [2 ,3 ]
Yang, Xia [2 ,3 ]
Wei, Hong-Yuan [2 ,4 ]
Chen, Yue [1 ,4 ]
机构
[1] Southwest Med Univ, Dept Nucl Med, Affiliated Hosp, Luzhou 646000, Peoples R China
[2] China Acad Engn Phys, Inst Nucl Phys & Chem, Mianyang 621900, Peoples R China
[3] Lab Targeted Radiopharmaceut Creat, Mianyang 621900, Peoples R China
[4] Key Lab Nucl Med & Mol Imaging Sichuan Prov, Luzhou 646000, Peoples R China
基金
中国国家自然科学基金;
关键词
Fab fragments; Lutetium-177; Anti-EGFR antibody; Biodistribution; Lung cancer; SQUAMOUS-CELL CARCINOMA; TARGETED THERAPY; RADIOIMMUNOTHERAPY; BIODISTRIBUTION; NECK; HEAD;
D O I
10.1007/s10967-025-10030-4
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Fab fragments obtained via enzymatic digestion of full-length antibodies or by gene recombination technology have smaller molecular weight and greater penetration ability. Those advantages make it uniquely suited to deliver radionuclides. In this study, we prepared a Fab fragment from the anti-EGFR antibody Cetuximab and labeled it with 177Lu. The binding activity in vitro and biodistribution in vivo of [177Lu]Lu-DOTA-Fab-Cetuximab were investigated. The [177Lu]Lu-labeled Fab fragment showed improved tumor penetration and faster blood clearance compared to the full-length antibody.
引用
收藏
页码:2139 / 2149
页数:11
相关论文
共 50 条
  • [1] In vitro and in vivo evaluation of a novel anti-EGFR antibody labeled with 89Zr and 177Lu
    Liu, Wei
    Li, Kehong
    Deng, Hao
    Wang, Jing
    Zhao, Peng
    Liao, Wei
    Zhuo, Liangang
    Wei, Hongyuan
    Yang, Xia
    Chen, Yue
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2022, 331 (02) : 747 - 754
  • [2] In vitro and in vivo evaluation of a novel anti-EGFR antibody labeled with 89Zr and 177Lu
    Wei Liu
    Kehong Li
    Hao Deng
    Jing Wang
    Peng Zhao
    Wei Liao
    Liangang Zhuo
    Hongyuan Wei
    Xia Yang
    Yue Chen
    Journal of Radioanalytical and Nuclear Chemistry, 2022, 331 : 747 - 754
  • [3] Influence of chelator type on in vitro receptor binding and stability in 177Lu-labeled anti-EGFR monoclonal antibodies
    Novy, Z.
    Laznickova, A.
    Mandikova, J.
    Laznicek, M.
    Trejtnar, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S429 - S429
  • [4] Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody
    Ehlerding, Emily B.
    Lacognata, Saige
    Jiang, Dawei
    Ferreira, Carolina A.
    Goel, Shreya
    Hernandez, Reinier
    Jeffery, Justin J.
    Theuer, Charles P.
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) : 123 - 131
  • [5] Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody
    Emily B. Ehlerding
    Saige Lacognata
    Dawei Jiang
    Carolina A. Ferreira
    Shreya Goel
    Reinier Hernandez
    Justin J. Jeffery
    Charles P. Theuer
    Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 123 - 131
  • [6] Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
    Song, In Ho
    Lee, Tae Sup
    Parke, Yong Serk
    Lee, Jin Sook
    Lee, Byung Chul
    Moon, Byung Seok
    An, Gwang Il
    Lee, Hae Won
    Kim, Kwang Il
    Lee, Yong Jin
    Kang, Joo Hyun
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1105 - 1111
  • [7] A 177Lu-labeled anti-HER2 dual variable domain antibody
    MacPherson, Douglas
    Hwang, Dobeen
    Sarrett, Samantha
    Rodriguez, Cindy
    Keinaenen, Outi
    Rader, Christoph
    Zeglis, Brian
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S9 - S9
  • [8] Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
    Wurzer, Alexander
    Kunert, Jan-Philip
    Fischer, Sebastian
    Felber, Veronika
    Beck, Roswitha
    de Rose, Francesco
    D'Alessandria, Calogero
    Weber, Wolfgang
    Wester, Hans-Jurgen
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1489 - 1495
  • [9] Comparative cytotoxicity of 177Lu on various lung cancer cells and in vivo targeting of 177Lu-labeled cetuximab
    Li, Kehong
    Fan, Wenqi
    Yan, Jingxuan
    Wang, Jing
    Zhao, Peng
    Liao, Wei
    Yang, Yuchuan
    Yang, Xia
    Wei, Hongyuan
    Chen, Yue
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2023, 332 (06) : 2093 - 2102
  • [10] 177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
    Du, Huan
    Hao, Xiaofei
    Lin, Binwei
    Tang, Mingming
    Wang, Decai
    Yang, Xia
    Wang, Jing
    Qin, Liling
    Yang, Yuchuan
    Du, Xiaobo
    JOURNAL OF NUCLEAR MEDICINE, 2025, 66 (03) : 377 - 384